Haemonetics (HAE)
(Delayed Data from NYSE)
$85.85 USD
+0.24 (0.28%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $85.71 -0.14 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
HAE 85.85 +0.24(0.28%)
Will HAE be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for HAE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HAE
Best Momentum Stocks to Buy for June 6th
New Strong Buy Stocks for June 6th
HAE: What are Zacks experts saying now?
Zacks Private Portfolio Services
These 3 Companies Boast Bright Outlooks
Best Momentum Stocks to Buy for June 4th
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
Other News for HAE
These 3 Companies Boast Bright Outlooks
Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares
Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE)
HAE Crosses Below Key Moving Average Level
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes